![Mitsuyoshi Azuma](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Mitsuyoshi Azuma
Director/Miembro de la Junta en Senju Pharmaceutical Co., Ltd. .
Cargos activos de Mitsuyoshi Azuma
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Senju Pharmaceutical Co., Ltd.
![]() Senju Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Senju Pharmaceutical Co., Ltd. manufactures and distributes pharmaceuticals. It produces drugs for inflammation, allergy, glaucoma, cataract, and infection. The company was founded on April 9, 1947 and is headquartered in Osaka, Japan. | Director/Miembro de la Junta | - | - |
Corporate Officer/Principal | - | - | |
Neuroptika, Inc.
![]() Neuroptika, Inc. Pharmaceuticals: MajorHealth Technology Neuroptika, Inc. operates as biotechnology company which develops drugs for eye diseases and nerves regeneration. The company was founded by Chiho Fukiage and in November 2018 and is headquartered in Cambridge, MA. | Director/Miembro de la Junta | - | - |
Historial de carrera de Mitsuyoshi Azuma
Antiguos cargos conocidos de Mitsuyoshi Azuma.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
SemaThera, Inc.
![]() SemaThera, Inc. BiotechnologyHealth Technology SemaThera, Inc. engages in research and development in biotechnology. It develops novel inhibitors against semaphorin 3A (SEMA 3A) for prevention and reversal of diabetic macular edema (DME). The company is headquartered in Montreal, Canada. | Director/Miembro de la Junta | - | - |
Estadísticas
Internacional
Japón | 2 |
Estados Unidos | 2 |
Canadá | 2 |
Operativa
Director/Board Member | 3 |
Corporate Officer/Principal | 1 |
Sectorial
Health Technology | 4 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 3 |
---|---|
Senju Pharmaceutical Co., Ltd.
![]() Senju Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Senju Pharmaceutical Co., Ltd. manufactures and distributes pharmaceuticals. It produces drugs for inflammation, allergy, glaucoma, cataract, and infection. The company was founded on April 9, 1947 and is headquartered in Osaka, Japan. | Health Technology |
Neuroptika, Inc.
![]() Neuroptika, Inc. Pharmaceuticals: MajorHealth Technology Neuroptika, Inc. operates as biotechnology company which develops drugs for eye diseases and nerves regeneration. The company was founded by Chiho Fukiage and in November 2018 and is headquartered in Cambridge, MA. | Health Technology |
SemaThera, Inc.
![]() SemaThera, Inc. BiotechnologyHealth Technology SemaThera, Inc. engages in research and development in biotechnology. It develops novel inhibitors against semaphorin 3A (SEMA 3A) for prevention and reversal of diabetic macular edema (DME). The company is headquartered in Montreal, Canada. | Health Technology |
- Bolsa de valores
- Insiders
- Mitsuyoshi Azuma
- Experiencia